Physical binding pocket induction for affinity prediction. Read more about Physical binding pocket induction for affinity prediction.
Divergent modes of enzyme inhibition in a homologous structure-activity series. Read more about Divergent modes of enzyme inhibition in a homologous structure-activity series.
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling. Read more about Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
Promiscuous aggregate-based inhibitors promote enzyme unfolding. Read more about Promiscuous aggregate-based inhibitors promote enzyme unfolding.
6-Azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor. Read more about 6-Azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor.
Reductive heme-dependent activation of the n-oxide prodrug AQ4N by nitric oxide synthase. Read more about Reductive heme-dependent activation of the n-oxide prodrug AQ4N by nitric oxide synthase.
Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. Read more about Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.
Unsaturated cationic ortho esters for endosome permeation in gene delivery. Read more about Unsaturated cationic ortho esters for endosome permeation in gene delivery.
Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins. Read more about Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins.
Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. Read more about Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
